JESSICA SANDERS: Open Payments
NPI 1003231416 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 15 payments from 9 companies in 2025. Trend: 2023 $226 · 2024 $1,180 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Valinor Pharma, LLC | 2 | $30 |
| Averitas Pharma Inc. | 1 | $29 |
| Nalu Medical, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
Products named: WaveWriter Alpha Prime 16, RELISTOR, JOURNAVX, MOVANTIK, QUTENZA, Nalu Neurostimulation System, KYPHON EXPRESS II KYPHOPAK TRAY, HORIZANT.
Industry payments across GA — which companies pay providers there.
